Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis

M. Wozniakova, J. Skarda, M. Raska

. 2022 ; 28 (-) : 1610502. [pub] 20220721

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22025173

Colorectal cancer (CRC) is one of the most common cancers worldwide. The patient's prognosis largely depends on the tumor stage at diagnosis. The pathological TNM Classification of Malignant Tumors (pTNM) staging of surgically resected cancers represents the main prognostic factor and guidance for decision-making in CRC patients. However, this approach alone is insufficient as a prognostic predictor because clinical outcomes in patients at the same histological tumor stage can still differ. Recently, significant progress in the treatment of CRC has been made due to improvements in both chemotherapy and surgical management. Immunotherapy-based approaches are one of the most rapidly developing areas of tumor therapy. This review summarizes the current knowledge about the tumor microenvironment (TME), immune response and its interactions with CRC development, immunotherapy and prognosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025173
003      
CZ-PrNML
005      
20221031100527.0
007      
ta
008      
221017s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/pore.2022.1610502 $2 doi
035    __
$a (PubMed)35936516
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Wozniakova, Maria $u Institute of Pathology and Molecular Genetics, University Hospital Ostrava, Ostrava, Czechia $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czechia
245    14
$a The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis / $c M. Wozniakova, J. Skarda, M. Raska
520    9_
$a Colorectal cancer (CRC) is one of the most common cancers worldwide. The patient's prognosis largely depends on the tumor stage at diagnosis. The pathological TNM Classification of Malignant Tumors (pTNM) staging of surgically resected cancers represents the main prognostic factor and guidance for decision-making in CRC patients. However, this approach alone is insufficient as a prognostic predictor because clinical outcomes in patients at the same histological tumor stage can still differ. Recently, significant progress in the treatment of CRC has been made due to improvements in both chemotherapy and surgical management. Immunotherapy-based approaches are one of the most rapidly developing areas of tumor therapy. This review summarizes the current knowledge about the tumor microenvironment (TME), immune response and its interactions with CRC development, immunotherapy and prognosis.
650    12
$a kolorektální nádory $x patologie $7 D015179
650    _2
$a lidé $7 D006801
650    _2
$a imunita $7 D007109
650    _2
$a imunoterapie $7 D007167
650    _2
$a prognóza $7 D011379
650    12
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Skarda, Jozef $u Institute of Pathology and Molecular Genetics, University Hospital Ostrava, Ostrava, Czechia $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czechia
700    1_
$a Raska, Milan $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czechia
773    0_
$w MED00180530 $t Pathology oncology research $x 1532-2807 $g Roč. 28, č. - (2022), s. 1610502
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35936516 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100525 $b ABA008
999    __
$a ok $b bmc $g 1854732 $s 1176463
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 28 $c - $d 1610502 $e 20220721 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace